Please Wait
Applying Filters...
menu
    • menu
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma CDMO offers integrated end-to-end solutions for development & commercialization of intermediates & APIs for small molecules.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    veranova-m-2025-06-30

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Olmesartan

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 681Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Amneal's Generic Olmesartan Medoxomil Receives Approval in the U.S.
    Amneal's Generic Olmesartan Medoxomil Receives Approval in the U.S.

    11 Jul 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207480

    FDA
    11 Jul 2023
    Share Share
    Macleods' Generic Olmesartan Medoxomil and Hydrochlorothiazide Receives Receives Approval in the U.S.
    Macleods' Generic Olmesartan Medoxomil and Hydrochlorothiazide Receives Receives Approval in the U.S.

    01 Jun 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204801

    FDA
    01 Jun 2023
    Share Share
    MSN's Generic Olmesartan Medoxomil Receives Approval in the U.S.
    MSN's Generic Olmesartan Medoxomil Receives Approval in the U.S.

    18 Jan 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217399

    FDA
    18 Jan 2023
    Share Share
    Prinston's Generic Olmesartan Medoxomil Receives Approval in the U.S.
    Prinston's Generic Olmesartan Medoxomil Receives Approval in the U.S.

    02 Dec 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206720

    FDA
    02 Dec 2022
    Share Share
    IOL Chemicals secures patent for invention related to preparation of Sartan drugs
    IOL Chemicals secures patent for invention related to preparation of Sartan drugs

    27 Nov 2022

    // BUSINESS-STANDARD

    https://www.business-standard.com/article/news-cm/iol-chemicals-secures-patent-for-invention-related-to-preparation-of-sartan-drugs-122112400926_1.html

    BUSINESS-STANDARD
    27 Nov 2022
    Share Share
    Macleods Pharmaceuticals recalls products in US for manufacturing issues
    Macleods Pharmaceuticals recalls products in US for manufacturing issues

    28 Mar 2022

    // BUSINESS-STANDARD

    https://www.business-standard.com/article/companies/macleods-pharmaceuticals-recalls-products-in-us-for-manufacturing-issues-122031300189_1.html

    BUSINESS-STANDARD
    28 Mar 2022
    Share Share